Senomyx, Inc. (NASDAQ:SNMX)

No debt, good amount of cash, spending lots on R&D and has a great market with obesity only increasing in America. Their latest results show them improving, although not profitable yet, they are only a quarter or two off. They have lots of promising products in the pipeline and have too huge of an upside not to get in early.

Low Sales and Return on Equity

pjani06

NOW THE SNMX 2011 SHORT SQUEEZE!!!!
=D

Picks (made 1/25/11): SNMX, PCBCD, LNG, ARNA)

ROYALTIES STARTING TO KICK IN THIS YEAR...ONCD ROYALTIES RAMP, DOUBTERS WILL HAVE TO BELIEVE - HUGE IP PORTFOLIO. STRONG CASH POSITION - KEY PROGRAMS GETTING GOING. TIME TO OWN IS NOW.

Senomyx is on the verge of seeing its collaborators adopt, use, and sell their flavor enhancers. At least three companies will be using and selling Senomxy's enhancers in 2010 and with new approvals on sucrose enhancers due in the near future, 2011 should see further adoption. Senomyx is finally seeing adoption of their unique products and is very attractively priced for the potential revenue this company could garner 5, 10, and 20 years later.

Company has developed an alternative to common sweetners that is a new technology that is a sweetner enhancer. They have just received approval to market. Coca Cola has an investment in this firm. It has the advantage of not needing to depend on farms (sugar) etc., and can be produced in unlkimited quanitites. .

Working with a lot of big name food companies... expecting it to green up.

Pure speculation. I like the science behind their product. If they can pull it off, and improve the taste of soft drinks and soups while cutting the amount of sugar and salt, the stock should be a big winner. However, if they fail, expect to lose it all.

Companies are always looking in reduce costs and with the increased demand on commodities companies are going to be looking for ways to reduce cost without losing flavor. I think there are going to be bumps along the way, but SNMX will eventually be included in a lot of the products we buy.

Although this company has yet to record a profit, Senomyx, along with Redpoint Bio, and Allylix (similar companies) are using pharmaceutical technologies and business models to reinvent the flavor market. Each hopes that one or more of its products will become the food industries version of a blockbuster drug. The potential demand and market for these flavors is enormous. For example, Senomyx is currently under contract with coca-cola. How much coca-cola is sold worldwide do you think? The flavor industry meats bio-tech. Goldmine in the long run.

This past weekend I was at the Franchise expo in Washington DC and TASTE is the number 1 reason why you would be INTERESTED in putting money into a franchise such as... Robeks, Wings Over, Froots, etc etc.. Now, with these companies hiring the like's of Senomyx to keep up with other foods in their market this stock has a potential to get back in the $10-12 point in the next two-three years

This stock is all about risk/rewards. If a single one of their flavor compounds is successful, expect huge gains in the stock, let alone if they were successful across the board.

Senomyx develops flavor additives with a patented technology based on how "Taste" is experienced from the Bio-Chemical perspestive. Low salt foods can be made to 'Taste' salty. Soybean products can be made less 'bitter'. MSG ( Mono sodiuj glutamate ) can be taken out and the taste can still be 'Savory''. SNMX is working with a number ogFood Companies like Campbell Soup. I think they have great products, a pipeline of NEW products being developed in partnership with the customers who want them AND -- SNMX could be a Take-Over target for any number of companies who need "Taste" in their businesses. Bottom Line -- A Take-Over PLAY !!!

Had them on my watch list for over a year now, a very interesting little company. I like their prospects.

VALUE LINES - WORST PERFORMING STOCKS 13 WEEKS

Sounds tasty!

This company uses biotechnology to improve the taste of packaged foods and beverages. Large food and beverage companies license its technology (e.g., bitter blockers, etc.) to make health food taste more like regular food. Tremendous room for growth. Consumers want to eat healthier foods, but they won't compromise taste for wellness.

Attempt to "cash in" on the momentum of this stock after first commercial product launch announcement.